Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Diabetes Care

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.29.01.06.DC05-1670PMID 16373901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy.

  2005cited by this paper
• Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy.

  2004cited by this paper
• Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy.

  2004cited by this paper
• CCN proteins: multifunctional signalling regulators.

  2004cited by this paper
• Function and localization of urate transporter 1 in mouse kidney.

  2004cited by this paper
• Connective Tissue Growth Factor Is a Mediator of Angiotensin II–Induced Fibrosis

  2003cited by this paper
• Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina

  2003cited by this paper
• Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.

  2003cited by this paper
• Urinary CCN2 (CTGF) as a possible predictor of diabetic nephropathy: preliminary report.

  2003cited by this paper
• Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.

  2002cited by this paper
• Pathogenesis of fibrosis: role of TGF-beta and CTGF.

  2002cited by this paper
• Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.

  2001cited by this paper
• Blood Levels of Alpha-1-Antichymotrypsin and Risk Factors for Alzheimer’s Disease: Effects of Gender and Apolipoprotein E Genotype

  2000cited by this paper
• Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.

  2000cited by this paper
• Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.

  2000cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Suppression Subtractive Hybridization Identifies High Glucose Levels as a Stimulus for Expression of Connective Tissue Growth Factor and Other Genes in Human Mesangial Cells*

  1999cited by this paper
• Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

  1999cited by this paper
• Expression of connective tissue growth factor in experimental rat and human liver fibrosis

  1999cited by this paper
• Expression of connective tissue growth factor in human renal fibrosis.

  1998cited by this paper
• Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia.

  1998cited by this paper
• Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.

  1996cited by this paper
• Histopathology of diabetic retinopathy in man

  1993cited by this paper
• Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10

  1991cited by this paper
• Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II

  1990cited by this paper

• Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine

  2026cites this paper
• The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study.

  2024cites this paper
• Application of Proteomics and Machine Learning Methods to Study the Pathogenesis of Diabetic Nephropathy and Screen Urinary Biomarkers.

  2024cites this paper
• Unveiling Selected Influences on Chronic Kidney Disease Development and Progression

  2024cites this paper
• Néphropathie diabétique

  2023cites this paper
• Connective tissue growth factor among elderly patients with type 2 diabetes: Correlation with diabetic nephropathy

  2023cites this paper
• Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy

  2023cites this paper
• Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches

  2022cites this paper
• Roles and crosstalks of macrophages in diabetic nephropathy

  2022cites this paper
• Novel biomarkers for prognosticating diabetic kidney disease progression

  2022cites this paper
• Exploration of Matrix Metalloproteinase and its Interplay in the Development of Diabetic Nephropathy

  2021cites this paper
• Diabetic nephropathy: A twisted thread to unravel.

  2021cites this paper
• Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis

  2021cites this paper
• Macrophage Phenotype and Fibrosis in Diabetic Nephropathy

  2020cites this paper
• Connective Tissue Growth Factor in Normal and Pathological Processes

  2020cites this paper
• Augmented transcripts of kidney injury markers and renin angiotensin system in urine samples of overweight young adults

  2020cites this paper
• Possible Biomarkers for Diabetic Kidney Disease

  2020cites this paper
• Urinary Biomarkers of Renal Fibrosis.

  2019cites this paper
• Investigation of Mechanisms That Are Involved in The Pathogenesis of Diabetic Angiopathy and Nephropathy and Development of Indicators of Scouting Diagnosis of The Above Complications in Diabetes Mellitus Type1

  2019cites this paper
• Is there any relation between connective tissue growth factor and scar tissue in vesicoureteral reflux?

  2019cites this paper
• Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients

  2019cites this paper
• NEPHROPATHIC AND DIABETIC NEPHROPATHIC EVALUATION VIA EPIGENETICAL MODIFICATION

  2019cites this paper
• Combination Low Carbohydrate, High Fat Diet and Physical Activity Intervention on Lipoprotein-Lipids in Type 2 Diabetics

  2019cites this paper
• Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis

  2018cites this paper
• Roles of the TGF-β–VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis

  2018cites this paper
• A Review on Diabetic Neuropathy

  2018cites this paper
• Connective tissue growth factor (CTGF) from basics to clinics.

  2018cites this paper
• Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy

  2017cites this paper
• Effects of Averrhoa carambola L. (Oxalidaceae) juice mediated on hyperglycemia, hyperlipidemia, and its influence on regulatory protein expression in the injured kidneys of streptozotocin-induced diabetic mice.

  2017cites this paper
• ELISA of CCN Family Proteins in Body Fluids Including Serum and Plasma.

  2017cites this paper
• EARLY POSTPARTUM LIPID PROFILE IN WOMEN WITH AND WITHOUT GESTATIONAL DIABETES MELLITUS: RESULTS OF A PROSPECTIVE COHORT STUDY

  2017cites this paper
• Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis

  2017cites this paper
• Novel Biomarkers for Early Diagnosis and Progression of Diabetic Nephropathy

  2016cites this paper
• High glucose-induced cytoplasmic translocation of Dnmt3a contributes to CTGF hypo-methylation in mesangial cells

  2016cites this paper
• Novel Biomarkers for Renal Diseases? None for the Moment (but One)

  2016cites this paper
• Effects of Triptergium Glycosides on Expressions of MCP- 1 and CTGF in Rats with Early Diabetic Nephropathy

  2016cites this paper
• The Onset and Resolution of Renal Fibrosis: A Human Perspective

  2016cites this paper
• Chapter 54 – Diabetic Nephropathy

  2016cites this paper
• New frontiers in fibrotic disease therapies: The focus of the Joan and Joel Rosenbloom Center for Fibrotic Diseases at Thomas Jefferson University.

  2016cites this paper
• The role of CTGF in diabetic retinopathy.

  2015cites this paper
• Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer

  2015cites this paper
• Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction

  2015cites this paper
• Diabetic nephropathy: What does the future hold?

  2015cites this paper
• TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2

  2015cites this paper
• Biomarkers in chronic kidney disease, from kidney function to kidney damage.

  2015cites this paper
• Connective tissue growth factor and the cicatrization of cellular crescents in ANCA-associated glomerulonephritis.

  2015cites this paper
• Macrophage-derived Tumor Necrosis Factor-α mediates diabetic renal injury

  2015cites this paper
• Biomarkers of renal function, which and when?

  2015cites this paper
• Urinary biomarkers for early diabetic nephropathy: beyond albuminuria

  2015cites this paper
• Zhao lupus nephritis The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and

  2014cites this paper
• The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis

  2014cites this paper
• Novel Urinary Biomarkers in Early Diabetic Kidney Disease

  2014cites this paper
• Connective Tissue Growth Factor Is Involved in Structural Retinal Vascular Changes in Long-Term Experimental Diabetes

  2014cites this paper
• Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease

  2014cites this paper
• Effects of triptergium glycosides on the expression of MCP-1 and CTGF in rats with early diabetic nephropathy

  2014cites this paper
• Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF

  2014cites this paper
• Université de Montréal-Thèse numérique

  2014cites this paper
• Markers of and risk factors for the development and progression of diabetic kidney disease.

  2014cites this paper
• Protective effect of statin therapy on connective tissue growth factor induction by diabetes in vivo and high glucose in vitro

  2013cites this paper
• Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy.

  2013cites this paper
• Macrophages directly mediate diabetic renal injury.

  2013cites this paper
• Chemokines and macrophage migration inhibitory factor in diabetic nephropathy

  2013cites this paper
• The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes

  2013cites this paper
• The C-terminal module IV of connective tissue growth factor is a novel immune modulator of the Th17 response

  2013cites this paper
• Connective tissue growth factor, matrix regulation, and diabetic kidney disease

  2013cites this paper
• Evaluation of matricellular proteins as potential therapeutics for the treatment of human chronic skin wounds

  2013cites this paper
• Novel therapies for diabetic kidney disease.

  2013cites this paper
• Gene therapy, a targeted treatment for diabetic nephropathy.

  2013cites this paper
• Connective Tissue Growth Factor (CTGF) Expression Modulates Response to High Glucose

  2013cites this paper
• Urinary Connective Tissue Growth Factor Is Associated with Human Renal Allograft Fibrogenesis

  2013cites this paper
• Urinary biomarkers of diabetic nephropathy

  2013cites this paper
• Therapeutic Modalities in Diabetic Nephropathy: Standard and Emerging Approaches

  2012cites this paper
• Quercetin Ameliorates Diabetic Nephropathy by Reducing the Expressions of Transforming Growth Factor-β1 and Connective Tissue Growth Factor in Streptozotocin-Induced Diabetic Rats

  2012cites this paper
• Vectorial secretion of CTGF as a cell-type specific response to LPA and TGF-β in human tubular epithelial cells

  2012cites this paper
• Oncostatin M inhibits TGF-β1-induced CTGF expression via STAT3 in human proximal tubular cells.

  2012cites this paper
• Effect of houttuynia cordata aetherolea on adiponectin and connective tissue growth factor in a rat model of diabetes mellitus.

  2012cites this paper
• Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.

  2012influential citation
• Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy.

  2012cites this paper
• CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

  2012cites this paper
• Extracellular matrix-associated (GAGs, CTGF), angiogenic (VEGF) and inflammatory factors (MCP-1, CD40, IFN-γ) in type 1 diabetes mellitus nephropathy

  2012cites this paper
• Biomarkers in Acute and Chronic Kidney Diseases

  2012cites this paper
• Pathophysiology and Complications of Diabetes Mellitus

  2012cites this paper
• Effects of interventions in the RAAS and sodium status on classical and non-classical outcome parameters in chronic kidney disease

  2012cites this paper
• TGF-β and CTGF : pro-fibrotic factors in diabetic retinopathy

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Connective tissue growth factor in renal development and injury

  2011cites this paper
• Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.

  2011cites this paper
• A risk-analysis approach to the evaluation of analytical quality

  2011cites this paper
• Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Connective tissue growth factor in renal development and injury

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Connective tissue growth factor in renal development and injury

  2011cites this paper
• In Reply to ‘Does High or Low Urinary Connective Tissue Growth Factor Predict CKD?’

  2011cites this paper
• Does high or low urinary connective tissue growth factor predict CKD?

  2011cites this paper
• Pathophysiology of the diabetic kidney.

  2011cites this paper
• Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.

  2011cites this paper
• Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion.

  2010cites this paper
• Involvement of Connective Tissue Growth Factor in Human and Experimental Hypertensive Nephrosclerosis

  2010cites this paper
• Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate.

  2010cites this paper
• Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria.

  2010cites this paper
• Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy

  2010cites this paper
• The Acute Effect of Clamped Hyperglycemia on the Urinary Excretion of Inflammatory Cytokines/Chemokines in Uncomplicated Type 1 Diabetes

  2010cites this paper